Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
17.08 USD | +1.22% | +7.39% | +12.51% |
Apr. 18 | Alx Oncology Holdings Insider Sold Shares Worth $710,195, According to a Recent SEC Filing | MT |
Apr. 10 | ALX Oncology Reports Positive Data From Ongoing Phase 1/2 Trial of Evorpacept | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+12.51% | 852M | |
-3.11% | 103B | |
+0.45% | 95.71B | |
+0.90% | 22.02B | |
-17.27% | 20.9B | |
-9.54% | 17.85B | |
-42.83% | 16.21B | |
-16.32% | 15.52B | |
+4.57% | 13.86B | |
+30.33% | 12.04B |
- Stock Market
- Equities
- ALXO Stock
- News ALX Oncology Holdings Inc.
- ALX Oncology : HC Wainwright Starts ALX Oncology Holdings at Buy With $100 Price Target